A tiny implanted device to check how drugs act inside brain tumors
Original title: Implantable Microdevice In Primary Brain Tumors
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
This is an early safety test in a small number of people.
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This trial tests a small device placed in a brain tumor to see how drugs act there.
Who this trial is for. This trial is for people with a malignant brain tumor. It tests a small device, called a microdevice, placed in the tumor to measure how the tumor responds to drugs. The drugs are ones already given for gliomas.
Where it stands. The trial is checking if the device is safe and if the approach works. It is an early, small pilot study. It has not reported results, so there is no answer yet.
What this means, and what it doesn't
What it could mean: If this works, doctors may one day learn how a tumor responds to drugs sooner. For now it is only being tested. Someone who fits the trial could ask their care team about it.
What it doesn't mean: This does not mean the device is proven or ready for regular care. A trial is a test, not a treatment you can count on. Joining one is not a guarantee that it will help you. It is not a promise of a cure.
Source: ClinicalTrials.gov, October 16, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.